However, there are some general guidelines that may help
A method of reversing, ameliroating or slowing progression of at least one symptom of Parkinson's disease in a patient in need thereof, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to reverse, ameliorate or slow progression of said at least one symptom of Parkinson's disease, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 wherein Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Some individual peptides have been approved by the FDA for specific medical uses (e.g., insulin, liraglutide)
Net debt/EBITDA is low at 0.4x post-IPO (estimated net cash), which is better than Syngene (1.1x) and Lonza (2.3x)
Children Use and dose will be determined by your physician